{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:06:21Z","timestamp":1792483581469,"version":"4.5.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.rmr.2022.01.005","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T05:30:16Z","timestamp":1647322216000},"page":"275-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique\u00a0\u2013\u00a0Actualisation 2021. Version courte"],"prefix":"10.1016","volume":"39","author":[{"given":"V.","family":"Cottin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bonniaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jouneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marchand-Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"W\u00e9meau-Stervinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bergot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Borie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chenivesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gondouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hirschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lebargy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-H.","family":"Marquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pr\u00e9vot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Quetant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reynaud-Gaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salaun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Trumbic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Berkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-Y.","family":"Brillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Chalabreysse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chatt\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Debieuvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Fourrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kambouchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Le Guillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Lhuillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mehdaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Naccache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paganon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"R\u00e9my-Jardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Si-Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Terrioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2022.01.005_bib0760","doi-asserted-by":"crossref","first-page":"1602419","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0765","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.rmr.2013.09.007","volume":"30","author":"Cottin","year":"2013","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2022.01.005_bib0770","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.rmr.2017.07.017","volume":"34","author":"Cottin","year":"2017","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2022.01.005_bib0775","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0780","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0785","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0790","first-page":"697","article-title":"Fleischner Society: Glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology. 2008. Radiology"},{"key":"10.1016\/j.rmr.2022.01.005_bib0795","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1148\/radiol.12112516","article-title":"Interobserver variability in the CT assessment of honeycombing in the lungs","volume":"266","author":"Watadani","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2022.01.005_bib0800","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1148\/radiology.211.2.r99ma01555","article-title":"Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129\u00a0patients","volume":"211","author":"Johkoh","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2022.01.005_bib0805","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1164\/ajrccm.164.2.2101090","article-title":"Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis","volume":"164","author":"Hunninghake","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0810","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1148\/radiology.205.1.9314990","article-title":"Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung","volume":"205","author":"Swensen","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2022.01.005_bib0815","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201602-0402OC","article-title":"Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria","volume":"195","author":"Raghu","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0820","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.124.4.1215","article-title":"Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia","volume":"124","author":"Hunninghake","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib0825","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.12.9437","article-title":"UIP diagnosed at surgical lung biopsy, 2000-2009: HRCT patterns and proposed classification system","volume":"200","author":"Gruden","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2022.01.005_bib0830","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/thx.2010.137190","article-title":"Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease","volume":"66","author":"Tcherakian","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.01.005_bib0835","doi-asserted-by":"crossref","first-page":"101009","DOI":"10.1016\/j.eclinm.2021.101009","article-title":"Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: survival analysis using visual and computer-based computed tomography assessment","volume":"38","author":"Gudmundsson","year":"2021","journal-title":"EClinicalMed"},{"key":"10.1016\/j.rmr.2022.01.005_bib0840","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/13993003.01680-2015","article-title":"Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia","volume":"47","author":"Yagihashi","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0845","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201508-1632OC","article-title":"In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States","volume":"193","author":"Hutchinson","year":"2016","journal-title":"2000\u00a0to 2011. Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0850","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1183\/13993003.00378-2016","article-title":"Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008","volume":"48","author":"Hutchinson","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0855","doi-asserted-by":"crossref","first-page":"1801164","DOI":"10.1183\/13993003.01164-2018","article-title":"Procedure volume and mortality after surgical lung biopsy in interstitial lung disease","volume":"53","author":"Fisher","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0860","first-page":"1197","article-title":"Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal lung disease. A meta-analysis of diagnostic test accuracy","volume":"14","author":"Iftikhar","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2022.01.005_bib0865","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000484055","article-title":"Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the Cryobiopsy Working Group on safety and utility and a call for standardization of the procedure","volume":"95","author":"Hetzel","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2022.01.005_bib0870","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000444089","article-title":"Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature","volume":"91","author":"Ravaglia","year":"2016","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2022.01.005_bib0875","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S2213-2600(19)30342-X","article-title":"Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study","volume":"8","author":"Troy","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0880","doi-asserted-by":"crossref","first-page":"891","DOI":"10.5858\/arpa.2016-0233-RA","article-title":"Transbronchial cryobiopsy in diffuse lung disease: update for the pathologist","volume":"141","author":"Colby","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0885","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1164\/rccm.201504-0711OC","article-title":"Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis","volume":"193","author":"Tomassetti","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0890","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0895","doi-asserted-by":"crossref","first-page":"104021","DOI":"10.1016\/j.lpm.2020.104021","article-title":"Diagnostic approach of fibrosing interstitial lung diseases of unknown origin","volume":"49","author":"Cottin","year":"2020","journal-title":"Presse Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0900","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0905","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease","volume":"185","author":"Meyer","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0910","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/rccm.200808-1313OC","article-title":"Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis","volume":"179","author":"Ohshimo","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0915","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0920","doi-asserted-by":"crossref","first-page":"2000206","DOI":"10.1183\/13993003.00206-2020","article-title":"Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis","volume":"56","author":"Adderley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0925","doi-asserted-by":"crossref","first-page":"1901144","DOI":"10.1183\/13993003.01144-2019","article-title":"Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern","volume":"54","author":"Tzilas","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0930","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1183\/13993003.02115-2015","article-title":"Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis","volume":"48","author":"Borie","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0935","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1183\/13993003.00308-2016","article-title":"Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive","volume":"48","author":"Newton","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0940","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1164\/rccm.200408-1104OC","article-title":"Clinical and pathologic features of familial interstitial pneumonia","volume":"172","author":"Steele","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0945","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.200906-0953OC","article-title":"Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort","volume":"182","author":"van Moorsel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0950","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jmedgenet-2016-103973","article-title":"Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine","volume":"54","author":"Spagnolo","year":"2017","journal-title":"Journal of medical genetics"},{"key":"10.1016\/j.rmr.2022.01.005_bib0955","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.chest.2018.03.026","article-title":"Diagnostic ability of a dynamic multidisciplinary discussion in interstitial lung diseases: a retrospective observational study of 938\u00a0cases","volume":"153","author":"De Sadeleer","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib0960","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12916-016-0562-1","article-title":"Any fool can make a rule and any fool will mind it\u201d","volume":"14","author":"Wells","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0965","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1164\/rccm.201903-0493OC","article-title":"Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis","volume":"200","author":"Walsh","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0970","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00131912","article-title":"Prevalence and prognosis of unclassifiable interstitial lung disease","volume":"42","author":"Ryerson","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib0975","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1513\/AnnalsATS.201801-067OC","article-title":"Heterogeneity in unclassifiable interstitial lung disease. A systematic review and meta-analysis","volume":"15","author":"Guler","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2022.01.005_bib0980","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1164\/rccm.201011-1790OC","article-title":"Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis","volume":"184","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0985","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0990","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1479972316674425","article-title":"Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch","volume":"14","author":"Wapenaar","year":"2017","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.rmr.2022.01.005_bib0995","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2019-0328TR","article-title":"Pirfenidone: molecular mechanisms and potential clinical applications in lung disease","volume":"62","author":"Ruwanpura","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmr.2022.01.005_bib1000","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rmr.2022.01.005_bib1005","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3\u00a0trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/13993003.00026-2015","article-title":"Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3\u00a0trials","volume":"47","author":"Noble","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1015","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.201701-0091OC","article-title":"Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis","volume":"196","author":"Ley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chest.2018.11.008","article-title":"Efficacy of pirfenidone in the context of multiple disease progression events in patients with idiopathic pulmonary fibrosis","volume":"155","author":"Nathan","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib1025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000479976","article-title":"An open-label study of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (RECAP)","volume":"94","author":"Costabel","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2022.01.005_bib1030","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00084-2018","article-title":"Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study","volume":"4","author":"Cottin","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmr.2022.01.005_bib1035","article-title":"Predicting life expectancy for pirfenidone in idiopathic pulmonary fibrosis","volume":"23","author":"Fisher","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.rmr.2022.01.005_bib1040","doi-asserted-by":"crossref","first-page":"1701157","DOI":"10.1183\/13993003.01157-2017","article-title":"Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis","volume":"50","author":"van Manen","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1045","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/resp.12297","article-title":"Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Valeyre","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2022.01.005_bib1050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/09031936.00217614","article-title":"Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry","volume":"46","author":"Behr","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000496735","article-title":"A 2-year observational study in patients suffering from idiopathic pulmonary fibrosis and treated with pirfenidone: a French Ancillary Study of PASSPORT","volume":"98","author":"Jouneau","year":"2019","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2022.01.005_bib1060","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1007\/s12325-019-01052-y","article-title":"Cardiovascular risks, bleeding risks, and clinical events from 3\u00a0phase III trials of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"36","author":"Glassberg","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.rmr.2022.01.005_bib1065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12325-014-0112-1","article-title":"Pirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse events","volume":"31","author":"Costabel","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.rmr.2022.01.005_bib1070","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel mechanisms for the antifibrotic action of nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmr.2022.01.005_bib1080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1085","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/rccm.201503-0562OC","article-title":"Efficacy of nintedanib in idiopathic pulmonary fibrosis across prespecified subgroups in INPULSIS","volume":"193","author":"Costabel","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/thoraxjnl-2016-208710","article-title":"Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume","volume":"72","author":"Kolb","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.01.005_bib1100","doi-asserted-by":"crossref","first-page":"1801655","DOI":"10.1183\/13993003.01655-2018","article-title":"Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials","volume":"53","author":"Cottin","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.rmed.2016.02.001","article-title":"Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS((R)) trials","volume":"113","author":"Richeldi","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S2213-2600(18)30339-4","article-title":"Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON","volume":"7","author":"Crestani","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1874306402014010022","article-title":"Effects of nintedanib on quantitative lung fibrosis score in idiopathic pulmonary fibrosis","volume":"14","author":"Lancaster","year":"2020","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1120","doi-asserted-by":"crossref","first-page":"e000397","DOI":"10.1136\/bmjresp-2018-000397","article-title":"Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials","volume":"6","author":"Lancaster","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.rmr.2022.01.005_bib1125","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01797-2018","article-title":"Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials","volume":"54","author":"Noth","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12931-015-0276-5","article-title":"Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis","volume":"16","author":"Corte","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2022.01.005_bib1135","doi-asserted-by":"crossref","first-page":"1601592","DOI":"10.1183\/13993003.01592-2016","article-title":"Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry","volume":"49","author":"Jo","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12931-018-0845-5","article-title":"The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Guenther","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2022.01.005_bib1145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1164\/rccm.201902-0456OC","article-title":"Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis","volume":"200","author":"Dempsey","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1150","doi-asserted-by":"crossref","first-page":"1902279","DOI":"10.1183\/13993003.02279-2019","article-title":"Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry","volume":"56","author":"Behr","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1155","doi-asserted-by":"crossref","first-page":"15620","DOI":"10.1038\/s41598-020-72607-1","article-title":"Antifibrotic treatment improves clinical outcomes in patients with idiopathic pulmonary fibrosis: a propensity score matching analysis","volume":"10","author":"Kang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.rmr.2022.01.005_bib1160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/13993003.01966-2015","article-title":"Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function","volume":"48","author":"Albera","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1165","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(19)30255-3","article-title":"Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study","volume":"7","author":"Maher","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.rmed.2019.04.016","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment","volume":"153","author":"Nathan","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1175","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200304-597OC","article-title":"A study of the cough reflex in idiopathic pulmonary fibrosis","volume":"168","author":"Hope-Gill","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1180","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa1811737","article-title":"Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis","volume":"379","author":"Kolb","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-5223(03)00600-7","article-title":"Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis","volume":"126","author":"Thabut","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rmr.2022.01.005_bib1190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014-an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.rmr.2022.01.005_bib1195","article-title":"Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2022.01.005_bib1200","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1205","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.chest.2018.06.038","article-title":"Treatment of interstitial lung disease associated cough: CHEST Guideline and Expert Panel Report","volume":"154","author":"Birring","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib1210","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/resp.12989","article-title":"Health-related quality of life in idiopathic pulmonary fibrosis: data from the Australian IPF Registry","volume":"22","author":"Glaspole","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2022.01.005_bib1215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12931-017-0621-y","article-title":"Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry","volume":"18","author":"Kreuter","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.rmr.2022.01.005_bib1220","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"Dowman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2022.01.005_bib1225","doi-asserted-by":"crossref","first-page":"30629","DOI":"10.3402\/ecrj.v3.30629","article-title":"Opioids: an unexplored option for treatment of dyspnea in IPF","volume":"3","author":"Kohberg","year":"2016","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1230","first-page":"e121","article-title":"Home oxygen therapy for adults with chronic lung disease","volume":"202","author":"Jacobs","year":"2020","journal-title":"An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1235","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/resp.13829","article-title":"Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation","volume":"25","author":"Arizono","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.rmr.2022.01.005_bib1240","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S2213-2600(18)30289-3","article-title":"Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial","volume":"6","author":"Visca","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1245","doi-asserted-by":"crossref","first-page":"1900421","DOI":"10.1183\/13993003.00421-2019","article-title":"Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey","volume":"54","author":"Lim","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1250","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1183\/09031936.00081512","article-title":"Effects of in-patient pulmonary rehabilitation in patients with interstitial lung disease","volume":"42","author":"Huppmann","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1255","doi-asserted-by":"crossref","first-page":"00045","DOI":"10.1183\/23120541.00045-2019","article-title":"Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias","volume":"5","author":"Wallaert","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmr.2022.01.005_bib1260","doi-asserted-by":"crossref","first-page":"8498603","DOI":"10.1155\/2019\/8498603","article-title":"Pulmonary rehabilitation for exercise tolerance and quality of life in ipf patients: a systematic review and meta-analysis","volume":"2019","author":"Yu","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.rmr.2022.01.005_bib1265","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/thoraxjnl-2014-206583","article-title":"Palliative care for patients with advanced fibrotic lung disease: a randomised controlled phase II and feasibility trial of a community case conference intervention","volume":"70","author":"Bajwah","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.01.005_bib1270","doi-asserted-by":"crossref","first-page":"1801278","DOI":"10.1183\/13993003.01278-2018","article-title":"Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study","volume":"52","author":"Bajwah","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An International working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1280","doi-asserted-by":"crossref","first-page":"170050","DOI":"10.1183\/16000617.0050-2017","article-title":"Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis","volume":"26","author":"Kondoh","year":"2017","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2022.01.005_bib1285","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1183\/09031936.00122213","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure","volume":"43","author":"Johannson","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/thoraxjnl-2017-209967","article-title":"Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis","volume":"73","author":"Ses\u00e9","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2022.01.005_bib1295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S2213-2600(21)00354-4","article-title":"Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3\u00a0trial","volume":"10","author":"Naccache","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1300","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/rccm.201909-1818OC","article-title":"Thrombomodulin alfa for acute exacerbation of idiopathic pulmonary fibrosis. A randomized, double-blind placebo-controlled trial","volume":"201","author":"Kondoh","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1305","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2015.12.005","article-title":"The use of mechanical ventilation in patients with idiopathic pulmonary fibrosis in the United States: a nationwide retrospective cohort analysis","volume":"111","author":"Rush","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtcvs.2013.06.039","article-title":"Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia","volume":"147","author":"Gaudry","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rmr.2022.01.005_bib1315","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13546-012-0642-y","article-title":"Fibrose pulmonaire\u00a0: dans quels cas et sur quels crit\u00e8res envisager une admission en r\u00e9animation\u00a0?","volume":"22","author":"Mullier","year":"2013","journal-title":"R\u00e9animation"},{"key":"10.1016\/j.rmr.2022.01.005_bib1320","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1325","first-page":"148","article-title":"Pulmonary hypertension in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Nathan","year":"2012","journal-title":"Eur Respir Mon"},{"key":"10.1016\/j.rmr.2022.01.005_bib1330","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1378\/chest.129.3.746","article-title":"Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis","volume":"129","author":"Lettieri","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib1335","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1183\/09031936.00115511","article-title":"Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis","volume":"40","author":"Judge","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1340","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1345","doi-asserted-by":"crossref","first-page":"1801914","DOI":"10.1183\/13993003.01914-2018","article-title":"Pulmonary hypertension in chronic lung disease and hypoxia","volume":"53","author":"Nathan","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1350","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2008470","article-title":"Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease","volume":"384","author":"Waxman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1355","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00101212","article-title":"Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients","volume":"42","author":"Savarino","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-2600(18)30301-1","article-title":"Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2\u00a0trial","volume":"6","author":"Raghu","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1365","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2213-2600(13)70105-X","article-title":"Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials","volume":"1","author":"Lee","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1370","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S2213-2600(16)00067-9","article-title":"Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis","volume":"4","author":"Kreuter","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1375","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1378\/chest.12-2403","article-title":"Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis","volume":"144","author":"Ryerson","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib1380","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1164\/rccm.201612-2492OC","article-title":"Effect of emphysema extent on serial lung function in patients with idiopathic pulmonary fibrosis","volume":"196","author":"Cottin","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1385","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiol.2511080917","article-title":"Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings","volume":"251","author":"Akira","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2022.01.005_bib1390","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2559.2008.03183.x","article-title":"Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course","volume":"53","author":"Kawabata","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.rmr.2022.01.005_bib1395","first-page":"1700379","article-title":"Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases","volume":"50","author":"Katzenstein","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1400","doi-asserted-by":"crossref","first-page":"1700379","DOI":"10.1183\/13993003.00379-2017","article-title":"Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis","volume":"50","author":"Jacob","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1405","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1183\/09031936.00038709","article-title":"Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome","volume":"35","author":"Cottin","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1410","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1378\/chest.08-2776","article-title":"Obstructive sleep apnea is common in idiopathic pulmonary fibrosis","volume":"136","author":"Lancaster","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib1415","doi-asserted-by":"crossref","first-page":"1601934","DOI":"10.1183\/13993003.01934-2016","article-title":"Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis","volume":"49","author":"Gille","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmed.2018.12.018","article-title":"Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing","volume":"147","author":"Bosi","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1425","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.chest.2020.04.067","article-title":"CPAP adherence, mortality, and progression-free survival in interstitial lung disease and OSA","volume":"158","author":"Adegunsoye","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2022.01.005_bib1430","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1513\/AnnalsATS.201807-481OC","article-title":"Idiopathic pulmonary fibrosis and lung cancer. A systematic review and meta-analysis","volume":"16","author":"Brown","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2022.01.005_bib1435","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1513\/AnnalsATS.201808-510OC","article-title":"Outcomes of older patients with pulmonary fibrosis and non-small cell lung cancer","volume":"16","author":"Whittaker Brown","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2022.01.005_bib1440","doi-asserted-by":"crossref","first-page":"e0202360","DOI":"10.1371\/journal.pone.0202360","article-title":"Lung cancer in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"13","author":"JafariNezhad","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2022.01.005_bib1445","doi-asserted-by":"crossref","first-page":"190044","DOI":"10.1183\/16000617.0044-2019","article-title":"Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue","volume":"28","author":"Caminati","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2022.01.005_bib1450","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1455","doi-asserted-by":"crossref","first-page":"180100","DOI":"10.1183\/16000617.0100-2018","article-title":"Fibrosing interstitial lung diseases: knowns and unknowns","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2022.01.005_bib1460","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmr.2022.01.005_bib1465","doi-asserted-by":"crossref","first-page":"2002718","DOI":"10.1183\/13993003.02718-2020","article-title":"Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)","volume":"57","author":"Nasser","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1470","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1159\/000509556","article-title":"Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers","volume":"99","author":"Faverio","year":"2020","journal-title":"Respiration"},{"key":"10.1016\/j.rmr.2022.01.005_bib1475","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s12325-020-01578-6","article-title":"Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician survey","volume":"38","author":"Olson","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.rmr.2022.01.005_bib1480","doi-asserted-by":"crossref","first-page":"1800692","DOI":"10.1183\/13993003.00692-2018","article-title":"What's in a name? That which we call IPF, by any other name would act the same","volume":"51","author":"Wells","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1485","doi-asserted-by":"crossref","first-page":"2000085","DOI":"10.1183\/13993003.00085-2020","article-title":"The natural history of progressive fibrosing interstitial lung diseases","volume":"55","author":"Brown","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2022.01.005_bib1490","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1495","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1500","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S2213-2600(19)30341-8","article-title":"Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2\u00a0trial","volume":"8","author":"Maher","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib1505","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2022.01.005_bib0755","first-page":"2004538","article-title":"Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial","author":"Flaherty","year":"2021","journal-title":"Eur Respir J"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842522000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:23:14Z","timestamp":1760106194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842522000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":151,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0761842522000262"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2022.01.005","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique\u00a0\u2013\u00a0Actualisation 2021. Version courte","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2022.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}